中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
9期
125-126
,共2页
双岐三联活菌%溃疡性结肠炎%治疗效果
雙岐三聯活菌%潰瘍性結腸炎%治療效果
쌍기삼련활균%궤양성결장염%치료효과
Rrobiotics%Ulcerative colitis%Treatment
目的：探讨应用双岐三联活菌治疗溃疡性结肠炎的临床效果。方法选取2012年12月—2014年6月该院收治的溃疡性结肠炎患者50例，随机分成观察组和对照组，每组患者25例；对照组患者接受常规方式治疗，观察组在常规治疗的基础上，联合运用双岐三联活菌进行治疗，治疗周期两个月，观察比较两组患者的治疗效果。结果观察组患者痊愈9例(36.00%)，对照组患者痊愈2例(8.00%)，两组治愈率比较差异具有统计学意义(P<0.05)；观察组有效治疗23例，总有效率为92.00%，对照组有效治疗16例，总有效率为6400%，两组比较差异具有统计学意义(P<0.05)。结论溃疡性结肠炎患者在治疗中联合应用双岐三联活菌，治疗效果明显高于常规治疗，说明双岐三联活菌在溃疡性结肠炎治疗中作用明显，可有效应用于临床。
目的：探討應用雙岐三聯活菌治療潰瘍性結腸炎的臨床效果。方法選取2012年12月—2014年6月該院收治的潰瘍性結腸炎患者50例，隨機分成觀察組和對照組，每組患者25例；對照組患者接受常規方式治療，觀察組在常規治療的基礎上，聯閤運用雙岐三聯活菌進行治療，治療週期兩箇月，觀察比較兩組患者的治療效果。結果觀察組患者痊愈9例(36.00%)，對照組患者痊愈2例(8.00%)，兩組治愈率比較差異具有統計學意義(P<0.05)；觀察組有效治療23例，總有效率為92.00%，對照組有效治療16例，總有效率為6400%，兩組比較差異具有統計學意義(P<0.05)。結論潰瘍性結腸炎患者在治療中聯閤應用雙岐三聯活菌，治療效果明顯高于常規治療，說明雙岐三聯活菌在潰瘍性結腸炎治療中作用明顯，可有效應用于臨床。
목적：탐토응용쌍기삼련활균치료궤양성결장염적림상효과。방법선취2012년12월—2014년6월해원수치적궤양성결장염환자50례，수궤분성관찰조화대조조，매조환자25례；대조조환자접수상규방식치료，관찰조재상규치료적기출상，연합운용쌍기삼련활균진행치료，치료주기량개월，관찰비교량조환자적치료효과。결과관찰조환자전유9례(36.00%)，대조조환자전유2례(8.00%)，량조치유솔비교차이구유통계학의의(P<0.05)；관찰조유효치료23례，총유효솔위92.00%，대조조유효치료16례，총유효솔위6400%，량조비교차이구유통계학의의(P<0.05)。결론궤양성결장염환자재치료중연합응용쌍기삼련활균，치료효과명현고우상규치료，설명쌍기삼련활균재궤양성결장염치료중작용명현，가유효응용우림상。
objective To investigate the clinical effect of application of Bifidobacterium triple viable in the treatment of ulcerative colitis.Methods 50 patients with ulcerative colitis from 2012 December to 2014 June in our hospital patients, randomly divided into observation group and control group, 25 cases in each group of patients; patients in control group received conventional modes of therapy, the observation group in the conventional treatment based on the joint use, Bifidobacterium triple viable treatment, two month treatment period, to observe the therapeutic effect of two groups were compared.Results the patients in the observation group 7 cases were cured (28%), the control group were cured in 2 cases (8%), the cure rate of two group with significant difference (p<0.05); observation group was effective in the treatment of 23 cases, the total effective rate was 92%, control group 17 cases of effective treatment, the total effective rate was 68%, two group of comparison, with statistically significant difference (p<0.05).Conclusion Patients with ulcerative colitis in the treatment of combined application of Bifid Triple Viable, the effect of treatment was significantly higher than thatof conventional treatment, Bifid Triple Viable shows obvious effect in the treatment of ulcerative colitis, can be effectively applied to clinical.
